Literature DB >> 7507026

Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS).

J W Semple1, D Allen, W Chang, P Castaldi, J Freedman.   

Abstract

Rapid purification of human lymphocyte subpopulations is an essential step in order to elucidate their interactions and/or contributions in various disease states. Cell purification using a Magnetic Activated Cell Sorter (MACS) is a relatively new technology which has been shown to be rapid and yield highly purified populations of cells. This report describes both a simple one-step positive selection method using the MACS to purify either human CD4+ or CD19+ lymphocytes from PBMC and a sequential separation of both CD4+ and CD19+ cell populations. These methods can separate the cell populations in approximately 4 h with yields > 90% and purity of 97 +/- 3% for CD4+ T cells and 92 +/- 5% for CD19+ B cells. In functional studies, purified CD19+ B cells secreted 13- and 24-fold more IgM and IgG, respectively, than the CD19- cell fraction in 10 day B cell stimulation assays. Purification of the two cell types did not cause any significant activation as shown by proliferation. Both cell types, however, were able to proliferate upon stimulation with interleukin-2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507026     DOI: 10.1002/cyto.990140816

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  10 in total

1.  Differential analysis of human leukocytes by dielectrophoretic field-flow-fractionation.

Authors:  J Yang; Y Huang; X B Wang; F F Becker; P R Gascoyne
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

2.  Rapid multitarget immunomagnetic separation through programmable DNA linker displacement.

Authors:  Christine E Probst; Pavel Zrazhevskiy; Xiaohu Gao
Journal:  J Am Chem Soc       Date:  2011-10-11       Impact factor: 15.419

3.  On-chip magnetophoretic isolation of CD4 + T cells from blood.

Authors:  Jeff Darabi; Chuan Guo
Journal:  Biomicrofluidics       Date:  2013-09-11       Impact factor: 2.800

4.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

Authors:  D M Klinman; A K Yi; S L Beaucage; J Conover; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

5.  Activation requirements and responses to TLR ligands in human CD4+ T cells: comparison of two T cell isolation techniques.

Authors:  Christina L Lancioni; Jeremy J Thomas; Roxana E Rojas
Journal:  J Immunol Methods       Date:  2009-03-09       Impact factor: 2.303

6.  Association of Kaposi's sarcoma associated herpesvirus (KSHV) DNA in bronchoalveolar lavage fluid of HIV infected individuals with bronchoscopically diagnosed tracheobronchial Kaposi's sarcoma.

Authors:  M R Howard; N S Brink; D Whitby; R S Tedder; R F Miller
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

7.  Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles.

Authors:  Jason E Jaetao; Kimberly S Butler; Natalie L Adolphi; Debbie M Lovato; Howard C Bryant; Ian Rabinowitz; Stuart S Winter; Trace E Tessier; Helen J Hathaway; Christian Bergemann; Edward R Flynn; Richard S Larson
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

8.  Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification.

Authors:  Paul A Lyons; Maria Koukoulaki; Alexander Hatton; Karen Doggett; Hayley B Woffendin; Afzal N Chaudhry; Kenneth G C Smith
Journal:  BMC Genomics       Date:  2007-03-05       Impact factor: 3.969

Review 9.  Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells.

Authors:  Mohammed I Khan; Anna M Czarnecka; Igor Helbrecht; Ewa Bartnik; Fei Lian; Cezary Szczylik
Journal:  Stem Cell Res Ther       Date:  2015-09-16       Impact factor: 6.832

10.  Cytotoxic activity of CD4+ T cells against autologous tumor cells.

Authors:  Y Konomi; T Sekine; T Takayama; M Fuji; T Tanaka
Journal:  Jpn J Cancer Res       Date:  1995-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.